Skip to content

Cartilage, bone and synovium

TL;DR — Cartilage extracellular-matrix degradation is a hallmark of OA; the pericellular matrix transduces biochemical and biomechanical signals, while abnormal subchondral remodeling, angiogenesis and innervation can contribute to cartilage damage and pain (Rapp 2023, PMID 36571440; Guilak 2018, PMID 29800616; Hu 2021, PMID 33731688).

Decision frame

This page was audited against 30 live-refetched PubMed records on 2026-08-31. It distinguishes evidence about diagnosis or symptoms from evidence about structure and does not treat association as proof of treatment effect.

Audit interpretation safeguards

  • A title establishes what a record studied, not the truth of every topic-adjacent statement.
  • Numerical results are used only when present in the live-fetched abstract or the cited report.
  • Association is not treated as treatment effect, and a protocol is not treated as a completed trial.
  • Systematic reviews inherit heterogeneity in population, intervention, comparator and outcome definition.

Cartilage matrix

Domain What the evidence supports What remains uncertain
Cartilage extracellular matrix Type II collagen and aggrecan are the most abundant cartilage-matrix components, and matrix degradation is a hallmark of OA. (Rapp 2023, PMID 36571440) The narrative review does not establish that targeting a single fragment will improve symptoms or structure.
Pericellular matrix The chondrocyte mechanosensory niche converts abnormal load into catabolic and reparative signals. (Guilak 2018, PMID 29800616) Individual effect size, phenotype specificity and durability require context-specific evidence.

Subchondral bone

Domain What the evidence supports What remains uncertain
Subchondral bone Abnormal remodeling, angiogenesis and sensory innervation in subchondral bone can contribute to cartilage destruction and pain. (Hu 2021, PMID 33731688) The review states that the exact role of subchondral bone in initiation and progression remains unclear.

Aggrecanase cleavage is causal in mice; the human target is not closed

Type II collagen and aggrecan dominate cartilage matrix, and pericellular-matrix mechanotransduction converts abnormal load into catabolic programs (Rapp 2023, PMID 36571440; Guilak 2018, PMID 29800616). The decisive mouse genetics: deleting the catalytic domain of ADAMTS5 (aggrecanase-2) reduced cartilage destruction after surgically induced instability — the first single-gene deletion shown to abrogate murine OA cartilage loss (Glasson 2005, PMID 15800624). Blocking only the interglobular-domain (IGD) cleavage site of aggrecan (leaving CS-2 cleavage intact) was enough to diminish erosion in both surgical OA and inflammatory arthritis and appeared to potentiate repair after acute inflammation (Little 2007, PMID 17510707). Whether this protection translates from these models to human OA remains unresolved.

Synovium is not a spectator

OA synovitis occurs in early and late disease and produces IL-1β, TNF, nitric oxide, PGE2 and neuropeptides that drive excess protease production; cartilage fragments then amplify synovitis — a loop, not a one-way “wear” sequence (Sellam 2010, PMID 20924410). IL-1β and TNF are prominent catabolic cytokines; IL-6, IL-15, IL-17, IL-18, IL-21, LIF and IL-8 are also implicated (Kapoor 2011, PMID 21119608). Synovial inflammation associates with both radiographic and pain progression; aging, obesity, trauma and mechanical load all modify synovial biology, with DAMPs, crystals, metabolites and mitochondrial dysfunction as activators (Sanchez-Lopez 2022, PMID 35165404). Group-level association of synovitis/effusion with pain is only weak-to-moderate and conflicting for CRP and many cytokines (Dainese 2022, PMID 34968719).

Subchondral bone: remodeling, angiogenesis, innervation

Abnormal subchondral remodeling, angiogenesis and sensory innervation can contribute to cartilage damage and pain; the review literature is explicit that the exact role in initiation versus progression remains unresolved (Hu 2021, PMID 33731688). Bone-targeted drugs (bisphosphonates, cathepsin K inhibition, strontium ranelate) have therefore been tested as DMOADs with mixed structural and negative or small symptom results — see disease-modifying therapies.

Evidence map

The table catalogs the retrieved studies used to bound this page. A title establishes the paper’s studied question; detailed numerical use requires the abstract or full text.

Study Design signal Evidence contribution Main transfer limit
Rapp 2023 (PMID 36571440) review Cartilage extracellular matrix-derived matrikines in osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Charni-Ben 2007 (PMID 17437662) review Monitoring cartilage turnover. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Li 2025 (PMID 41276868) review Mesenchymal stem cells and extracellular vesicles for knee osteoarthritis: clinical application, mechanism exploration and prospect. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Xu 2022 (PMID 36243371) systematic review Nanodevices for deep cartilage penetration. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Guilak 2018 (PMID 29800616) review Osteoarthritis as a disease of the cartilage pericellular matrix. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Luo 2017 (PMID 28213717) review The minor collagens in articular cartilage. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Little 2010 (PMID 20199393) review Is cartilage matrix breakdown an appropriate therapeutic target in osteoarthritis--insights from studies of aggrecan and collagen pr…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Martel-Pelletier 2008 (PMID 18455690) review Cartilage in normal and osteoarthritis conditions. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Troeberg 2012 (PMID 21777704) review Proteases involved in cartilage matrix degradation in osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Muttigi 2016 (PMID 27104523) review Matrilin-3 Role in Cartilage Development and Osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Hu 2021 (PMID 33158879) review Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Hu 2021 (PMID 33731688) review Subchondral bone microenvironment in osteoarthritis and pain. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Jiang 2022 (PMID 34801671) review Osteoarthritis year in review 2021: biology. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Li 2013 (PMID 24321104) review Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Zhu 2020 (PMID 33553146) review Subchondral Bone Remodeling: A Therapeutic Target for Osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Oláh 2023 (PMID 37742232) systematic review Subchondral bone remodeling patterns in larger animal models of meniscal injuries inducing knee osteoarthritis - a systematic review. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Liu 2025 (PMID 40757100) review Osteoarthritis: Mechanisms and Therapeutic Advances. Scope is verified from the live record; numerical transfer requires the abstract or full report.
De 2023 (PMID 37353140) review Fundamentals of osteoarthritis: Inflammatory mediators in osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Wang 2015 (PMID 25744069) review Current understanding of pathogenesis and treatment of TMJ osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Funck-Brentano 2015 (PMID 26002035) review Subchondral bone and osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Donell 2019 (PMID 31210964) review Subchondral bone remodelling in osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Knights 2023 (PMID 36695054) review Inflammation in osteoarthritis: the latest progress and ongoing challenges. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Dainese 2022 (PMID 34968719) systematic review Association between knee inflammation and knee pain in patients with knee osteoarthritis: a systematic review. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Mathiessen 2017 (PMID 28148295) review Synovitis in osteoarthritis: current understanding with therapeutic implications. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Geng 2023 (PMID 37745043) review Knee osteoarthritis: Current status and research progress in treatment (Review). Scope is verified from the live record; numerical transfer requires the abstract or full report.
Scanzello 2012 (PMID 22387238) review The role of synovitis in osteoarthritis pathogenesis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Sun 2020 (PMID 32081707) review The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Zeng 2021 (PMID 34975542) systematic review Benefits and Mechanisms of Exercise Training for Knee Osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Zhang 2020 (PMID 31982565) review Macrophages regulate the progression of osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Goldring 2011 (PMID 21788902) review Inflammation in osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.

Audit disposition

Check Result
PubMed identifiers 35/35 unique PMIDs resolved in the 2026-08-31 independent live E-utilities fetch
ClinicalTrials.gov identifiers None cited on this page
Author / year / journal Matched to live PubMed metadata; ePub/print offsets tolerated
Claim review Every remaining claim-to-citation pairing was checked against the live-fetched abstract or registry record; unsupported rows were deleted and overbroad claims were narrowed. No substantive citation issue remains.
## Open questions
  • Can an ADAMTS5 or IGD-selective aggrecanase inhibitor reproduce the Glasson/Little mouse protection in human knees without harming other tissues? (Glasson 2005, PMID 15800624; Little 2007, PMID 17510707)
  • Is synovitis a treatment target, a biomarker of load/injury, or both — and does reducing it change structure? (Sellam 2010, PMID 20924410; Sanchez-Lopez 2022, PMID 35165404)
  • Which subchondral event (remodeling, angiogenesis, innervation) is causal for pain in an individual? (Hu 2021, PMID 33731688)
  • Why have IL-1/TNF blockade and other anticytokine OA trials not matched the murine inflammatory story? (Kapoor 2011, PMID 21119608)

References

  1. Rapp AE, Zaucke F. Cartilage extracellular matrix-derived matrikines in osteoarthritis. Am J Physiol Cell Physiol. 2023;324(2);C377-C394. PMID 36571440
  2. Charni-Ben Tabassi N, Garnero P. Monitoring cartilage turnover. Curr Rheumatol Rep. 2007;9(1);16-24. PMID 17437662
  3. Li Y, Fu T, Yu W, et al. Mesenchymal stem cells and extracellular vesicles for knee osteoarthritis: clinical application, mechanism exploration and prospect. Stem Cell Res Ther. 2025;16(1);688. PMID 41276868
  4. Xu XL, Xue Y, Ding JY, et al. Nanodevices for deep cartilage penetration. Acta Biomater. 2022;154;23-48. PMID 36243371
  5. Guilak F, Nims RJ, Dicks A, et al. Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol. 2018;71-72;40-50. PMID 29800616
  6. Luo Y, Sinkeviciute D, He Y, et al. The minor collagens in articular cartilage. Protein Cell. 2017;8(8);560-572. PMID 28213717
  7. Little CB, Fosang AJ. Is cartilage matrix breakdown an appropriate therapeutic target in osteoarthritis--insights from studies of aggrecan and collagen proteolysis? Curr Drug Targets. 2010;11(5);561-75. PMID 20199393
  8. Martel-Pelletier J, Boileau C, Pelletier JP, et al. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008;22(2);351-84. PMID 18455690
  9. Troeberg L, Nagase H. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta. 2012;1824(1);133-45. PMID 21777704
  10. Muttigi MS, Han I, Park HK, et al. Matrilin-3 Role in Cartilage Development and Osteoarthritis. Int J Mol Sci. 2016;17(4);590. PMID 27104523
  11. Hu W, Chen Y, Dou C, et al. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis. 2021;80(4);413-422. PMID 33158879
  12. Hu Y, Chen X, Wang S, et al. Subchondral bone microenvironment in osteoarthritis and pain. Bone Res. 2021;9(1);20. PMID 33731688
  13. Jiang Y. Osteoarthritis year in review 2021: biology. Osteoarthritis Cartilage. 2022;30(2);207-215. PMID 34801671
  14. Li G, Yin J, Gao J, et al. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Arthritis Res Ther. 2013;15(6);223. PMID 24321104
  15. Zhu X, Chan YT, Yung PSH, et al. Subchondral Bone Remodeling: A Therapeutic Target for Osteoarthritis. Front Cell Dev Biol. 2020;8;607764. PMID 33553146
  16. Oláh T, Cucchiarini M, Madry H. Subchondral bone remodeling patterns in larger animal models of meniscal injuries inducing knee osteoarthritis - a systematic review. Knee Surg Sports Traumatol Arthrosc. 2023;31(12);5346-5364. PMID 37742232
  17. Liu W, Guo NY, Wang JQ, et al. Osteoarthritis: Mechanisms and Therapeutic Advances. MedComm (2020). 2025;6(8);e70290. PMID 40757100
  18. De Roover A, Escribano-Núñez A, Monteagudo S, et al. Fundamentals of osteoarthritis: Inflammatory mediators in osteoarthritis. Osteoarthritis Cartilage. 2023;31(10);1303-1311. PMID 37353140
  19. Wang XD, Zhang JN, Gan YH, et al. Current understanding of pathogenesis and treatment of TMJ osteoarthritis. J Dent Res. 2015;94(5);666-73. PMID 25744069
  20. Funck-Brentano T, Cohen-Solal M. Subchondral bone and osteoarthritis. Curr Opin Rheumatol. 2015;27(4);420-6. PMID 26002035
  21. Donell S. Subchondral bone remodelling in osteoarthritis. EFORT Open Rev. 2019;4(6);221-229. PMID 31210964
  22. Knights AJ, Redding SJ, Maerz T. Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr Opin Rheumatol. 2023;35(2);128-134. PMID 36695054
  23. Dainese P, Wyngaert KV, De Mits S, et al. Association between knee inflammation and knee pain in patients with knee osteoarthritis: a systematic review. Osteoarthritis Cartilage. 2022;30(4);516-534. PMID 34968719
  24. Mathiessen A, Conaghan PG. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res Ther. 2017;19(1);18. PMID 28148295
  25. Geng R, Li J, Yu C, et al. Knee osteoarthritis: Current status and research progress in treatment (Review). Exp Ther Med. 2023;26(4);481. PMID 37745043
  26. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2);249-57. PMID 22387238
  27. Sun K, Luo J, Guo J, et al. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020;28(4);400-409. PMID 32081707
  28. Zeng CY, Zhang ZR, Tang ZM, et al. Benefits and Mechanisms of Exercise Training for Knee Osteoarthritis. Front Physiol. 2021;12;794062. PMID 34975542
  29. Zhang H, Cai D, Bai X. Macrophages regulate the progression of osteoarthritis. Osteoarthritis Cartilage. 2020;28(5);555-561. PMID 31982565
  30. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23(5);471-8. PMID 21788902
  31. Glasson SS, Askew R, Sheppard B, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature. 2005;434:644-8. PMID 15800624
  32. Little CB, Meeker CT, Golub SB, et al. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest. 2007;117:1627-36. PMID 17510707
  33. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6:625-35. PMID 20924410
  34. Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7:33-42. PMID 21119608
  35. Sanchez-Lopez E, Coras R, Torres A, et al. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022;18:258-275. PMID 35165404